Searched for: in-biosketch:yes
person:radixa01
Diagnosis and Management of Acute HIV
Chapter by: Cowan, Ethan A.; McGowan, Joseph P.; Fine, Steven M.; Vail, Rona M.; Merrick, Samuel T.; Radix, Asa E.; Hoffmann, Christopher J.; Gonzalez, Charles J.
in: New York State Department of Health AIDS Institute Clinical Guidelines by
Baltimore : Johns Hopkins Press, 2021
pp. -
ISBN:
CID: 5096602
Diagnosis and Management of HIV-2 in Adults
Chapter by: Shah, Sanjiv S.; McGowan, Joseph P.; Fine, Steven M.; Vail, Rona; Merrick, Samuel T.; Radix, Asa; Hoffmann, Christopher J.; Gonzalez, Charles J.
in: New York State Department of Health AIDS Institute Clinical Guidelines by
Baltimore : Johns Hopkins Press, 2021
pp. -
ISBN:
CID: 5096572
Use of Injectable CAB/RPV LA as Replacement ART in Virally Suppressed Adults With HIV
Chapter by: Urbina, Antonio E.; McGowan, Joseph P.; Fine, Steven M.; Vail, Rona; Merrick, Samuel T.; Radix, Asa; Hoffmann, Christopher J.; Gonzalez, Charles J.
in: New York State Department of Health AIDS Institute Clinical Guidelines by
Baltimore : Johns Hopkins Press, 2021
pp. -
ISBN:
CID: 5096532
Management of Immune Reconstitution Inflammatory Syndrome (IRIS)
Chapter by: Brust, James C.M.; McGowan, Joseph P.; Fine, Steven M.; Merrick, Samuel T.; Radix, Asa E.; Vail, Rona M.; Stevens, Lyn C.; Hoffmann, Christopher J.; Gonzalez, Charles J.
in: New York State Department of Health AIDS Institute Clinical Guidelines by
Baltimore : Johns Hopkins Press, 2021
pp. -
ISBN:
CID: 5096612
PEP to Prevent HIV Infection
Chapter by: DeHaan, Elliot; McGowan, Joseph P.; Fine, Steven M.; Vail, Rona; Merrick, Samuel T.; Radix, Asa; Hoffmann, Christopher J.; Gonzalez, Charles J.
in: New York State Department of Health AIDS Institute Clinical Guidelines by
Baltimore : Johns Hopkins Press, 2021
pp. -
ISBN:
CID: 5096512
Prevention and Management of Hepatitis A Virus in Adults With HIV
Chapter by: Ojeda-Martinez, Hector I.; McGowan, Joseph P.; Fine, Steven M.; Vail, Rona; Merrick, Samuel T.; Radix, Asa; Hoffmann, Christopher J.; Gonzalez, Charles J.
in: New York State Department of Health AIDS Institute Clinical Guidelines by
Baltimore : Johns Hopkins Press, 2021
pp. -
ISBN:
CID: 5096592
Selecting an Initial ART Regimen
Chapter by: Urbina, Antonio E.; McGowan, Joseph P.; Fine, Steven M.; Vail, Rona; Merrick, Samuel T.; Radix, Asa; Hoffmann, Christopher J.; Gonzalez, Charles J.
in: New York State Department of Health AIDS Institute Clinical Guidelines by
Baltimore : Johns Hopkins Press, 2021
pp. -
ISBN:
CID: 5096542
HIV Testing During Pregnancy, at Delivery, and Postpartum
Chapter by: Wright, Rodney L.; McGowan, Joseph P.; Fine, Steven M.; Vail, Rona M.; Merrick, Samuel T.; Radix, Asa E.; Hoffmann, Christopher J.; Rodrigues, Jessica; Gonzalez, Charles J.
in: New York State Department of Health AIDS Institute Clinical Guidelines by
Baltimore : Johns Hopkins Press, 2021
pp. -
ISBN:
CID: 5096552
Laboratory Monitoring for Adverse Effects of ART
Chapter by: Shalev, Noga; McGowan, Joseph P.; Fine, Steven M.; Vail, Rona; Merrick, Samuel T.; Radix, Asa; Hoffman, Christopher J.; Gonzalez, Charles J.
in: New York State Department of Health AIDS Institute Clinical Guidelines by
Baltimore : Johns Hopkins Press, 2021
pp. -
ISBN:
CID: 5096562
Patient-centered practices for engaging transgender and gender diverse patients in clinical research studies
Asquith, Andrew; Sava, Lauren; Harris, Alexander B; Radix, Asa E; Pardee, Dana J; Reisner, Sari L
BACKGROUND:The purpose of this formative study was to assess barriers and facilitators to participation of transgender and gender diverse (TGD) patients in clinical research to solicit specific feedback on perceived acceptability and feasibility of research methods to inform creation of a multisite longitudinal cohort of primary care patients engaged in care at two community health centers. METHOD:Between September-November 2018, four focus groups (FGs) were convened at two community health centers in Boston, MA and New York, NY (N = 28 participants across all 4 groups; 11 in Boston and 17 in New York). FG guides asked about patient outreach, acceptability of study methods and measures, and ideas for study retention. FGs were facilitated by TGD study staff, lasted approximately 90 min in duration, were audio recorded, and then transcribed verbatim by a professional transcription service. Thematic analyses were conducted by two independent analysts applying a constant comparison method. Consistency and consensus were achieved across code creation and application aided by Dedoose software. RESULTS:Participants were a mean age of 33.9 years (SD 12.3; Range 18-66). Participants varied in gender identity with 4 (14.3%) men, 3 (10.7%) women, 8 (28.6%) transgender men, 10 (35.7%) transgender women, and 3 (10.7%) nonbinary. Eight (26.6%) were Latinx, 5 (17.9%) Black, 3 (10.7%) Asian, 3 (10.7%) another race, and 5 (17.9%) multiracial. Motivators and facilitators to participation were: research creating community, research led by TGD staff, compensation, research integrated into healthcare, research applicable to TGD and non-TGD people, and research helping TGD communities. Barriers were: being research/healthcare averse, not identifying as TGD, overlooking questioning individuals, research coming from a 'cisgender lens", distrust of how the research will be used, research not being accessible to TGD people, and research being exploitative. CONCLUSION:Though similarities emerged between the perspectives of TGD people and research citing perspectives of other underserved populations, there are barriers and facilitators to research which are unique to TGD populations. It is important for TGD people to be involved as collaborators in all aspects of research that concerns them.
PMCID:8487157
PMID: 34598674
ISSN: 1471-2288
CID: 5092662